B – Raw data availability from clinical trials

Doshi P, Goodman SN, Ioannidis JPA. Raw data from clinical trials: within reach? Trends in Pharmacological Sciences 2013;34(12):645-647
(doi: 10.1016/j.tips.2013.10.006)

Many scientific disciplines have accepted that raw data, protocols, and analysis codes should be widely available. Making raw data from clinical trials widely publically available should reduce selective reporting biases and enhance the reproducibility of and trust in clinical research. Some of the caveats and limitations in proposed data-sharing policies are potentially restrictive, and the authors argue in favor of more widespread availability of data from clinical research.